SAJA, founded in 1996, is a dynamic joint venture between Saudi healthcare leader Tamer Industries and Japanese pharmaceutical giants Daiichi Sankyo and Astellas Pharma. Pioneering since 2000, SAJA has expanded globally with a unique portfolio covering urology, cardiovascular, diabetes, oncology, specialty, primary care, and nutraceuticals. As a trusted licensee for pharmaceutical and bio-pharmaceutical companies, we boast a solid track record of successful collaborations with industry leaders. Our mission is to provide diversified therapeutics for healthier lives, making medicine accessible for all. We leverage our agility, reliability, resilience, and compliance, offering innovative solutions with a strategic focus on the MENA region.
